Leading pharmaceutical company, Sun Pharma on Tuesday after market hours reported 52.63%fall in consolidated profit at Rs635.88crore for the Q4quarter ended March 31. The Company had reported a net of Rs1342.50crore in the matching quarter last year. Total expenditure mounted 14.35% to Rs6751.21crore from Rs5904.23crore in the year-ago period. Revenue arrived at Rs7163.92crore against Rs6977.10crore on a yearly basis.
On closing, the stock settled 0.08% down at Rs414.50 on the NSE, while the NSE Nifty ended at 11928.75 up 4pts and the BSE Sensex closed 66.44-ptss lower at 39,749.43, on Tuesday.